Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Machine Learning and Experimental Validation Reveal MYH11 as a Novel Prognostic Biomarker and Therapeutic Target in Bladder Cancer

1 Jun 2025

Abstract excerpt

Introduction: Bladder cancer (BCa) is one of the top ten most common cancers, yet its underlying mechanisms remain unclear. This study aimed to explore the potential molecular mechanisms of BCa using multi-omics and single-cell analysis. Methods: First, differential analysis of transcriptome data related to BCa from public databases was performed, and a risk model was then developed using 101 different machine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Ferroptosis and cancer prognosis
Share to Single-cell and spatial transcriptomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 40589607
DOI: 10.2147/jir.s519719

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Machine Learning and Experimental Validation Reveal MYH11 as a Novel Prognostic Biomarker and Therapeutic Target in Bladder CancerPMID 40589607Read ↗

Integrated multi-omics analysis reveals key genetic, metabolic, and microbial drivers in bladder cancer insights into molecular subtyping and therapeutic approaches: A tumor marker prognostic studySemantic proximity Read ↗

Exploring prognostic DNA methylation genes in bladder cancer: a comprehensive analysisSemantic proximity Read ↗

Single-cell and bulk RNA-sequence identiﬁed ﬁbroblasts signature and CD8 + T-cell - ﬁbroblast subtype predicting prognosis and immune therapeutic response of bladder cancer, based on machine learning: bioinformatics multi-omics studySemantic proximity Read ↗

Integrating Multi-dimensional RNA Sequencing to Construct a Prognostic Risk Model for Bladder CancerSemantic proximity Read ↗

Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune LandscapesSemantic proximity Read ↗

A Five-Gene Stromal-EMT Signature Predicts Prognosis, Immunotherapy Resistance, and Therapeutic Vulnerability in Bladder CancerSemantic proximity Read ↗

Integrating single-cell RNA-seq to identify fibroblast-based molecular subtypes for predicting prognosis and therapeutic response in bladder cancerSemantic proximity Read ↗

Machine-learning prediction of a novel diagnostic model using mitochondria-related genes for patients with bladder cancerSemantic proximity Read ↗

Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic modelSemantic proximity Read ↗

Transcriptomics-Driven Machine Learning Models Accurately Predict Chemotherapy Response in Muscle-invasive Bladder CancerSemantic proximity Read ↗

Targeting Macrophage-Associated Core Genes for Prognostic Prediction and Therapeutic Insights in Bladder CancerSemantic proximity Read ↗

Multiomics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.